Bazer F W, Roberts R M, Thatcher W W
J Anim Sci. 1979;49 Suppl 2:35-45. doi: 10.1093/ansci/49.supplement_ii.35.
The process of reproduction in the mammalian female involves interactions between gonadal and placental steroids and, possibly, protein hormones such as placental lactogen, and the uterine endometrium. These interactions are discussed relative to available data from pigs and with the understanding that the concepts presented may not be directly applicable to other species. Swine embryos enter the uterus for continued development beyond the early blastocyst stage and, within the uterus, the spherical blastocyst, of about 2 mm diameter on day 12, undergoes rapid elongation to an organism of about 1 m in length by day 15 of pregnancy. During this period of elongation, the blastocyst appears to provide the chemical signal, presumably unconjugated estrogens, that allows for corpora lutea (CL) maintenance (luteostatic effect) and, therefore, continued production of progesterone by the CL which is essential for pregnancy. Estrogens from the blastocyst may exert their luteostatic effect on the uterus by causing prostaglandin F2 alpha, the presumed porcine uterine luteolysin, to be secreted in an exocrine (toward the uterine lumen) rather than an endocrine (toward the endometrial stroma and vasculature) direction during pregnancy. Consequently, prostaglandin F2 alpha is sequestered in the uterine lumen and does not become available, via the utero-ovarian vasculature, to exert its luteolytic effect. The potential steroid precursor(s) available to the trophoblast for estrogen synthesis appear to be produced through endometrial conversion of progesterone to unconjugated androgens, e.g., androstenedione and testosterone, and conjugated estrogens, e.g., estrone-sulfate and estradiol-sulfate. The estrogens may, in concert with progesterone and possibly other hormones, placental lactogen for example, act locally, i.e., at the site of placentation to: result in a luteostatic effect; increase uterine blood flow; enhance water, electrolyte and substrate (carbohydrate and amino acid) transport to the site of placentation and across the placenta; affect synthesis and secretion of macro-molecules (histotroph) by the uterine glands that serve as enzymes and (or) carrier molecules and control or modulate physiological and (or) biochemical events essential to placental and fetal development that are not understood.
哺乳动物雌性的生殖过程涉及性腺和胎盘类固醇之间的相互作用,可能还涉及蛋白质激素(如胎盘催乳素)与子宫内膜之间的相互作用。本文将结合猪的现有数据对这些相互作用进行讨论,并认为所提出的概念可能并不直接适用于其他物种。猪胚胎进入子宫,在囊胚早期阶段之后继续发育,在子宫内,直径约2毫米的球形囊胚在妊娠第12天迅速伸长,到妊娠第15天时长到约1米长。在伸长期间,囊胚似乎提供了化学信号,大概是未结合的雌激素,它能维持黄体(CL)(黄体静止作用),因此,CL能持续产生孕酮,这对妊娠至关重要。囊胚产生的雌激素可能通过使前列腺素F2α(推测为猪子宫溶黄体素)在妊娠期间以外分泌(朝向子宫腔)而非内分泌(朝向子宫内膜基质和脉管系统)的方向分泌,从而对子宫发挥其黄体静止作用。因此,前列腺素F2α被隔离在子宫腔内,无法通过子宫 - 卵巢脉管系统发挥其溶黄体作用。滋养层用于雌激素合成的潜在类固醇前体似乎是通过子宫内膜将孕酮转化为未结合的雄激素(如雄烯二酮和睾酮)以及结合雌激素(如硫酸雌酮和硫酸雌二醇)而产生的。雌激素可能与孕酮以及可能的其他激素(例如胎盘催乳素)协同作用,在局部起作用,即在胎盘形成部位:产生黄体静止作用;增加子宫血流量;增强水、电解质和底物(碳水化合物和氨基酸)向胎盘形成部位和穿过胎盘的转运;影响子宫腺合成和分泌作为酶和(或)载体分子的大分子(组织营养物质),并控制或调节胎盘和胎儿发育所必需但尚不清楚的生理和(或)生化事件。